Advertisement

Catheter-Related Infection

  • Shubjeet Kaur
  • Stephen O. Heard

Abstract

Intravascular catheters are an inherent part of medical practice and may be inserted for a wide variety of indications from the basic (administration of medications or fluids) to the complex (e.g., hemodynamic monitoring of critically ill patients). One significant risk associated with the use of these catheters is infection. The infection may be local (suppuration at the site of insertion), thereby resulting in patient discomfort and the inconvenience of changing the site, or systemic, resulting in bacteremia, osteomyelitis, or endocarditis. The annual incidence of catheter-related bloodstream infections (CRBSI) caused by central venous catheters in the intensive care unit is approximately 80,000 (1). Contrary to earlier studies, recent data suggest that when patients are stratified according to severity of illness, the mortality due to CRBSI is not increased. However, hospital length of stay and costs ($3,700 – $34,000 per episode) associated with treating the bacteremia are substantially increased (1,2). This chapter focuses on the pathogenesis, prevention, and treatment of catheter-related infections.

Keywords

Central Venous Catheter Infect Control Hosp Silver Sulfadiazine Catheter Colonization Nosocomial Bloodstream Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391–402PubMedGoogle Scholar
  2. 2.
    Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160: 976–81PubMedCrossRefGoogle Scholar
  3. 3.
    Pearson ML: Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24: 262–77PubMedCrossRefGoogle Scholar
  4. 4.
    Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Crit Care Med 1992; 20: 665–73PubMedCrossRefGoogle Scholar
  5. 5.
    Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994; 271: 1014–6PubMedCrossRefGoogle Scholar
  6. 6.
    Timsit JF, Farkas JC, Boyer JM, Martin JB, Misset B, Renaud B, Cadet J. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998; 114: 207–13PubMedCrossRefGoogle Scholar
  7. 7.
    Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887–92PubMedCrossRefGoogle Scholar
  8. 8.
    Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598–601PubMedCrossRefGoogle Scholar
  9. 9.
    Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342: 710–21PubMedCrossRefGoogle Scholar
  10. 10.
    Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305–9PubMedCrossRefGoogle Scholar
  11. 11.
    Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis 1980; 141: 781–6PubMedCrossRefGoogle Scholar
  12. 12.
    Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28: 76–82PubMedGoogle Scholar
  13. 13.
    Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997; 35: 641–6PubMedGoogle Scholar
  14. 14.
    Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct gram staining of catheter segments. N Engl J Med 1985; 312: 1142–7PubMedCrossRefGoogle Scholar
  15. 15.
    Zufferey J, Rime B, Francioli P, Bille J. Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J Clin Microbiol 1988; 26: 175–7PubMedGoogle Scholar
  16. 16.
    Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995; 20: 593–7PubMedCrossRefGoogle Scholar
  17. 17.
    van Heerden PV, Webb SA, Fong S, Golledge CL, Roberts BL, Thompson WR. Central venous catheters revisited—infection rates and an assessment of the new Fibrin Analysing System brush. Anaesth Intensive Care 1996; 24: 330–3PubMedGoogle Scholar
  18. 18.
    Kite P, Dobbins BM, Wilcox MH, McMahon MJ. Rapid diagnosis of central-venous-catheterrelated bloodstream infection without catheter removal. Lancet 1999; 354: 1504–7PubMedCrossRefGoogle Scholar
  19. 19.
    Fan ST, Teoh-Chan CH, Lau KF. Evaluation of central venous catheter sepsis by differential quantitative blood culture. Eur J Clin Microbiol Infect Dis 1989; 8: 142–4PubMedCrossRefGoogle Scholar
  20. 20.
    Quilici N, Audibert G, Conroy MC, Bollaert PE, Guillemin F, Welfringer P, Garric J, Weber M, Laxenaire MC. Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in intensive care units. Clin Infect Dis 1997; 25: 1066–70PubMedCrossRefGoogle Scholar
  21. 21.
    Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, Laplanche A, Brun-Buisson C, Tancrede C. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354: 1071–7PubMedCrossRefGoogle Scholar
  22. 22.
    Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JR Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15: 95–102PubMedCrossRefGoogle Scholar
  23. 23.
    Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, Klein JP. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution. A randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18: 1269–1278PubMedGoogle Scholar
  24. 24.
    Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napotitano LM, Edwards LP, O’Connell FM, Puyana JC, Doern GV. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998; 158: 81–7PubMedCrossRefGoogle Scholar
  25. 25.
    Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339–43PubMedCrossRefGoogle Scholar
  26. 26.
    Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K, Brun-Buisson C. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996; 24: 1818–23PubMedCrossRefGoogle Scholar
  27. 27.
    Little JR, Murray PR, Traynor PS, Spitznagel E. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med 1999; 107: 119–25PubMedCrossRefGoogle Scholar
  28. 28.
    Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15: 231–8PubMedCrossRefGoogle Scholar
  29. 29.
    Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91: 197S - 205SPubMedCrossRefGoogle Scholar
  30. 30.
    Timsit JF, Sebille V, Farkas JC, Misset B, Martin JB, Chevret S, Carlet J. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276: 1416–20PubMedCrossRefGoogle Scholar
  31. 31.
    Timsit JF, Bruneel F, Cheval C, Mamzer MF, Garrouste-Orgeas M, Wolff M, Misset B, Chevret S, Regnier B, Carlet J. Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med 1999; 130: 729–35PubMedGoogle Scholar
  32. 32.
    Cohen Y, Fosse JP, Karoubi P, Reboul-Marty J, Dreyfuss D, Hoang P, Cupa M. The “hands-off” catheter and the prevention of systemic infections associated with pulmonary artery catheter: a prospective study. Am J Respir Crit Care Med 1998; 157: 284–7PubMedCrossRefGoogle Scholar
  33. 33.
    McCarthy MC, Shives JK, Robison RI, Broadie TA: Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. WEN J Parenter Enteral Nutr 1987; 11: 259–62CrossRefGoogle Scholar
  34. 34.
    Pemberton LB, Lyman B, Lander V, Covinsky J. Sepsis from triple-vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients. Arch Surg 1986; 121: 591–4PubMedCrossRefGoogle Scholar
  35. 35.
    Powell C, Fabri PJ, Kudsk KA. Risk of infection accompanying the use of single-lumen vs double-lumen subclavian catheters: a prospective randomized study. WEN J Parenter Enteral Nutr 1988; 12: 127–9CrossRefGoogle Scholar
  36. 36.
    Farkas JC, Liu N, Bleriot JP, Chevret S, Goldstein FW, Carlet J. Single-versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med 1992; 93: 277–82PubMedCrossRefGoogle Scholar
  37. 37.
    Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 1992; 267: 2072–6PubMedCrossRefGoogle Scholar
  38. 38.
    Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981; 70: 739–44PubMedCrossRefGoogle Scholar
  39. 39.
    Flowers RH 3d, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 1989; 261: 878–83PubMedCrossRefGoogle Scholar
  40. 40.
    Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158: 473–7PubMedCrossRefGoogle Scholar
  41. 41.
    Gales BJ, Gales MJ. Nutritional support teams: a review of comparative trials. Ann Pharmacother 1994; 28: 227–35PubMedGoogle Scholar
  42. 42.
    Berthelot P, Zeni F, Pain P, Berthier S, Aubert G, Venet C, Gery P, Lucht F, Bertrand JC. Catheter infection in intensive care: influence of systematic replacement of central venous catheters on a guide wire every 4 days. Presse Med 1997; 26: 1089–94PubMedGoogle Scholar
  43. 43.
    Eyer S, Bnunmitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990; 18: 1073–9PubMedCrossRefGoogle Scholar
  44. 44.
    Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA, Pruett TL, Schwenzer KJ, Farr BM. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992; 327: 1062–8PubMedCrossRefGoogle Scholar
  45. 45.
    Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168: 400–7PubMedCrossRefGoogle Scholar
  46. 46.
    Segura M, Alvarez-Lerma F, Tellado JM, Jimenez-Ferreres J, Oms L, Rello J, Baro T, Sanchez R, Morera A, Mariscal D, Marrugat J, Sitges-Serra A. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg 1996; 223: 363–9PubMedCrossRefGoogle Scholar
  47. 47.
    Halpin DP, O’Byme P, McEntee G, Hennessy TP, Stephens RB. Effect of a betadine connection shield on central venous catheter sepsis. Nutrition 1991; 7: 33–4PubMedGoogle Scholar
  48. 48.
    Lucet JC, Hayon J, Bruneel F, Dumoulin JL, Joly-Guillou ML. Microbiological evaluation of central venous catheter administration hubs. Infect Control Hosp Epidemiol 2000; 21: 40–2PubMedCrossRefGoogle Scholar
  49. 49.
    Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver- impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988; 85: 307–14PubMedCrossRefGoogle Scholar
  50. 50.
    Hasaniya NW, Angelis M, Brown MR, Yu M. Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections. Chest 1996; 109: 1030–2PubMedCrossRefGoogle Scholar
  51. 51.
    Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic- impregnated vascular catheters [published erratum appears in J Infect Dis 1993; 168(5):1342]. J Infect Dis 1993; 167: 920–4PubMedCrossRefGoogle Scholar
  52. 52.
    Appelgren P, Ransjo U, Bindslev L, Espersen F, Lann O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med 1996; 24: 1482–9PubMedCrossRefGoogle Scholar
  53. 53.
    Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997; 127: 257–66PubMedGoogle Scholar
  54. 54.
    Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281: 261–7PubMedCrossRefGoogle Scholar
  55. 55.
    Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282: 554–60PubMedCrossRefGoogle Scholar
  56. 56.
    Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter [published erratum appears in Anesthesiology 1998 Feb;88(2):560]. Anesthesiology 1997; 87: 1242–4Google Scholar
  57. 57.
    Smith CJ, Fitsgerald D, Brebbia JS, Brathwaite CEM. Central venous catheters and risk for resistance. Crit Care Med 2000; 27: A118CrossRefGoogle Scholar
  58. 58.
    Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265: 2364–8PubMedCrossRefGoogle Scholar
  59. 59.
    Thornton J, Todd NJ, Webster NR. Central venous line sepsis in the intensive care unit. A study comparing antibiotic coated catheters with plain catheters [published erratum appears in Anaesthesia 1997; 52(2):192]. Anaesthesia 1996; 51: 1018–20PubMedCrossRefGoogle Scholar
  60. 60.
    Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shenaq S, Curling P, Burke T, Ericsson C. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127: 267–74PubMedGoogle Scholar
  61. 61.
    Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340: 1–8PubMedCrossRefGoogle Scholar
  62. 62.
    Marik PE, Abraham G, Careau P, Varon J, Fromm RE, Jr.. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999; 27: 1128–31PubMedCrossRefGoogle Scholar
  63. 63.
    Pettigrew RA, Lang SD, Haydock DA, Parry BR, Bremner DA, Hill GL. Catheter-related sepsis in patients on intravenous nutrition: a prospective study of quantitative catheter cultures and guidewire changes for suspected sepsis. Br J Surg 1985; 72: 52–5PubMedCrossRefGoogle Scholar
  64. 64.
    Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 1992; 14: 75–82PubMedCrossRefGoogle Scholar
  65. 65.
    Fowler VG, Jr., Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong LK, Gottlieb G, Donovan CL, Sexton DJ, Ryan T. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30: 1072–8PubMedCrossRefGoogle Scholar
  66. 66.
    Benoit JL, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21: 1286–8PubMedCrossRefGoogle Scholar
  67. 67.
    Glynn MF, Langer B, Jeejeebhoy KN. Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. WEN J Parenter Enteral Nutr 1980; 4: 387–90CrossRefGoogle Scholar
  68. 68.
    Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, Albitar M, Sherertz RJ. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25: 149–51PubMedCrossRefGoogle Scholar
  69. 69.
    Worthley LI. Treatment of central venous silastic catheter infections using hydrochloric acid. Anaesth Intensive Care 1982; 10: 314–8PubMedGoogle Scholar
  70. 70.
    Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP: Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992; 13: 215–21PubMedCrossRefGoogle Scholar
  71. 71.
    Rose HD: Venous catheter-associated candidemia. Am J Med Sci 1978; 275: 265–9PubMedCrossRefGoogle Scholar
  72. 72.
    Lecciones JA, Lee JW, Navarro EE, Witebsky FG, Marshall D, Steinberg SM, Pizzo PA, Walsh Ti: Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992; 14: 875–83PubMedCrossRefGoogle Scholar
  73. 73.
    Nucci M, Colombo AL, Silveira F, Richtmann R, Salomao R, Branchini ML, Spector N: Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998; 19: 846–50PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Shubjeet Kaur
    • 1
  • Stephen O. Heard
    • 1
  1. 1.University of Massachusetts Medical CenterWorcesterUSA

Personalised recommendations